Bionano Genomics Inc [NASDAQ: BNGO] gained 22.87% or 0.1 points to close at $0.52 with a heavy trading volume of 3795954 shares.
The daily chart for BNGO points out that the company has recorded -57.98% loss over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 1.70M shares, BNGO reached to a volume of 3795954 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Bionano Genomics Inc [BNGO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BNGO shares is $4.40 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BNGO stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Scotiabank have made an estimate for Bionano Genomics Inc shares, keeping their opinion on the stock as Sector Outperform, with their previous recommendation back on January 05, 2023. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on December 12, 2022, representing the official price target for Bionano Genomics Inc stock. Previously, the target price had yet another raise to $12, while Oppenheimer analysts kept a Outperform rating on BNGO stock.
The Average True Range (ATR) for Bionano Genomics Inc is set at 0.06, with the Price to Sales ratio for BNGO stock in the period of the last 12 months amounting to 0.98. The Price to Book ratio for the last quarter was 0.46, with the Price to Cash per share for the same quarter was set at 0.43.
Trading performance analysis for BNGO stock
Bionano Genomics Inc [BNGO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.37. With this latest performance, BNGO shares dropped by -22.23% in over the last four-week period, additionally sinking by -57.98% over the last 6 months – not to mention a drop of -84.53% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BNGO stock in for the last two-week period is set at 45.74, with the RSI for the last a single of trading hit 52.06, and the three-weeks RSI is set at 42.91 for Bionano Genomics Inc [BNGO]. The present Moving Average for the last 50 days of trading for this stock 0.6443, while it was recorded at 0.4305 for the last single week of trading, and 1.0939 for the last 200 days.
Bionano Genomics Inc [BNGO]: A deeper dive into fundamental analysis
Bionano Genomics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.11 and a Current Ratio set at 1.63.
An analysis of Institutional ownership at Bionano Genomics Inc [BNGO]
The top three institutional holders of BNGO stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in BNGO stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in BNGO stock with ownership which is approximately 5.1238%.
